Spruce Street Capital »

Surrozen shares owned by Spruce Street Capital

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Spruce Street Capital from 13F filings

Historical chart of Spruce Street Capital investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Spruce Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Spruce Street Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $11M 432k 25.95

More positions owned by Spruce Street Capital

Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Relay Therapeutics (RLAY)
Lb Pharmaceuticals Com Shs (LBRX)
Relmada Therapeutics (RLMD)
Alto Neuroscience Com Shs (ANRO)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Savara (SVRA)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Enanta Pharmaceuticals (ENTA)
Perspective Therapeutics Com New (CATX)
Inflarx Nv (IFRX)
Surrozen Com New (SRZN)
Alumis (ALMS)

View all positions for Spruce Street Capital

Top funds holding Surrozen

TCG Crossover Management
Boxer Capital Management
Millennium Management
VR Adviser
Stempoint Capital
Spruce Street Capital
Braidwell
Vanguard Capital Management
5AM Venture Management
Kalehua Capital Management
Vestal Point Capital
Vivo Capital
Perceptive Advisors
Woodline Partners
Balyasny Asset Management

View all funds holding Surrozen